Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan
Drugs in R&D · 2024
DOI: 10.1007/s40268-024-00463-9 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Drugs in R&D, 2024. Verfasst von Brian P Mulherin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Oncology of Indiana, 8301 Harcourt Rd, Indianapolis, IN, 46260, USA. bmulhrn@yahoo.com. Hauptthemen laut MEDLINE: L-Lactate Dehydrogenase, Hemoglobinuria, Paroxysmal, Hemoglobins, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Apellis Pharmaceuticals, Swedish Orphan Biovitrum.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hematology Oncology of Indiana, 8301 Harcourt Rd, Indianapolis, IN, 46260, USA. bmulhrn@yahoo.com.
- Ascension St. Vincent Carmel, Carmel, IN, USA. bmulhrn@yahoo.com.
- Hematology Oncology of Indiana, 8301 Harcourt Rd, Indianapolis, IN, 46260, USA.
- Apellis Pharmaceuticals, Inc., Waltham, MA, USA.
- Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Förderung
- Apellis Pharmaceuticals
- Swedish Orphan Biovitrum
Zitieren
APA
Mulherin, B. P., Yeh, M., Al-Adhami, M., & Dingli, D. (2024). Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan. Drugs in R&D. https://doi.org/10.1007/s40268-024-00463-9
Vancouver
Mulherin BP, Yeh M, Al-Adhami M, Dingli D. Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan. Drugs in R&D. 2024. doi:10.1007/s40268-024-00463-9
BibTeX
@article{Mulherin2024,
author = {Mulherin, Brian P and Yeh, Michael and Al-Adhami, Mohammed and Dingli, David},
title = {Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan},
journal = {Drugs in R&D},
year = {2024},
doi = {10.1007/s40268-024-00463-9}
}
EUVIMED